DexRobot
Developer of high-degree-of-freedom dexterous robotic hands and end-effectors for humanoid and industrial robots.
Website: https://www.dex-robot.com/en
Cover Block
PUBLIC
| Name | DexRobot |
| Tagline | Developer of high-degree-of-freedom dexterous robotic hands and end-effectors for humanoid and industrial robots. |
| Headquarters | Shanghai, China |
| Founded | 2024 |
| Stage | Seed |
| Business Model | Hardware + Software |
| Industry | Deeptech |
| Technology | Robotics |
| Geography | East Asia |
| Growth Profile | Venture Scale |
| Founding Team | Academic Spinout |
| Funding Label | Undisclosed |
Links
PUBLIC
- Website: https://www.dex-robot.com/en
- LinkedIn: https://cn.linkedin.com/company/dex-robot
- Hugging Face: https://huggingface.co/DEXROBOT
Executive Summary
PUBLIC DexRobot is a Chinese deeptech startup developing high-degree-of-freedom robotic hands, a critical component for the emerging humanoid and advanced industrial automation markets, and warrants attention for its rapid technical development and strong academic backing [PRNewswire, March 2025]. Founded in January 2024, the company has quickly moved from concept to mass production of its flagship DexHand021, a five-finger, cable-driven hand with 19 degrees of freedom and integrated multi-modal sensors [arxiv.org, November 2025] [robotsci.com.cn, April 2025]. Its differentiation lies in a specialized, sensor-rich end-effector module designed to be integrated into existing robotic platforms, focusing on dexterous manipulation rather than building full robots from scratch [CanadaSatellite, 2024]. Public profiles emphasize the company's reliance on the scientific research strength of Shanghai Jiao Tong University and leadership from top-tier academicians of the Chinese Academy of Sciences, though specific named founders are not disclosed [AutomateShow, retrieved 2026]. DexRobot has secured venture funding, including a round in March 2026 from investors such as Yunsheng Fund Management, though the amounts and valuation remain undisclosed [Preqin, March 2026]. Over the next 12-18 months, the key milestones to watch will be the disclosure of commercial customer deployments and the translation of its academic pedigree into scalable sales execution.
Data Accuracy: YELLOW -- Product specifications and academic ties are well-documented; funding details are partial, and founder identities are not publicly confirmed.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Seed |
| Business Model | Hardware + Software |
| Industry / Vertical | Deeptech |
| Technology Type | Robotics |
| Geography | East Asia |
| Growth Profile | Venture Scale |
| Founding Team | Academic Spinout |
| Funding | Undisclosed |
Company Overview
PUBLIC
DexRobot emerged in early 2024 as a specialized hardware spinout, focusing its efforts on a single, critical component for advanced robotics: the dexterous hand. The company was formally established as Zhejiang DexRobot Technology Co., Ltd. in January of that year, with a primary operational base in Xinchang County, Shaoxing City, Zhejiang Province, China [Preqin, March 2026]. A second headquarters is maintained in Shanghai, positioning the firm between a major manufacturing hub and a leading academic and financial center [PRNewswire, March 2025].
The company's founding narrative is framed around its deep academic roots rather than individual founder biographies. Public profiles consistently describe DexRobot as relying on the scientific research strength of Shanghai Jiao Tong University and being led by top-tier academicians of the Chinese Academy of Sciences [AutomateShow, retrieved 2026]. This suggests an origin within university labs, with technical leadership drawn from senior faculty. While specific founder names are not disclosed in English-language sources, authors of a technical paper on the DexHand 021 are affiliated with the company, indicating key technical personnel [arxiv.org, November 2025].
Its commercial timeline appears accelerated. Within its first year, DexRobot had defined its flagship product, the DexHand021, and initiated mass production, according to a trade publication report from April 2025 [robotsci.com.cn, April 2025]. By March 2026, the company had secured venture funding from a consortium of Chinese investment firms, including Yunsheng Fund Management and Hangzhou Deyuan Anheng Private Equity Fund Management Co., Ltd., though the round size remains undisclosed [Preqin, March 2026]. LinkedIn data indicates the company has grown to an estimated 51-200 employees [LinkedIn, retrieved 2026].
Data Accuracy: YELLOW -- Key founding details and entity name confirmed by Preqin; employee range is a LinkedIn estimate. Specific founder identities and detailed milestone dates are not publicly available.
Product and Technology
MIXED
DexRobot's entire commercial proposition is built on a single, complex hardware component: a high-degree-of-freedom robotic hand. The company's flagship product, the DexHand021, is a five-finger, cable-driven design that achieves 19 degrees of freedom in a package weighing approximately one kilogram [arxiv.org, November 2025]. This dexterity is enabled by an underactuated tendon system, which allows for stable grasping and tool use with fewer individual motors than the number of joints, a common approach for balancing cost and functionality [Morningstar, June 2026]. The hand integrates 23 sensors for multi-modal perception, including position, temperature, multi-dimensional force, and proximity sensing, with a claimed force sensitivity of 0.1 Newtons [dex-robot.com, retrieved 2026]. This sensor suite is central to the company's claim of enabling "general intelligent multi-modal tactile-visual perception" for robotic manipulation [PRNewswire, March 2025].
Public materials differentiate between several product tiers. The DexHand021 MP (Mass Production) is positioned for continuous 24/7 industrial deployment, with a stated lifespan of over one million cycles and intelligent thermal management [dex-robot.com, retrieved 2026]. It is listed for sale at $26,150.00 [aifitlab.com, retrieved 2026]. The more advanced DexHand021 Pro integrates the wrist and hand, offering 22 degrees of freedom and is marketed as a component for humanoid robots [PRNewswire, March 2025]. The company states the hands support over 15 human-like grasping operations, such as cylindrical and spherical grips, and feature a modular design for flexible configuration based on application needs [robotsci.com.cn, April 2025]. A key public claim is that the DexHand021 has entered mass production [robotsci.com.cn, April 2025].
The technology is presented as a drop-in end-effector for a wide range of host systems. Target applications listed by the company include industrial automation, warehousing logistics, healthcare, and domestic services [dex-robot.com, retrieved 2026]. The product architecture suggests a focus on selling to robot original equipment manufacturers (OEMs) and system integrators rather than end-users directly. While the company website and press releases describe the hardware and its intended uses in detail, there is no public disclosure of the underlying software stack or control algorithms beyond generic references to "advanced intelligent algorithms" [robotsci.com.cn, April 2025]. The commercial availability and technical specifications of the products are [PUBLIC], but detailed performance benchmarks, software API documentation, and integration case studies are not publicly available.
Data Accuracy: GREEN -- Product specifications and claims are consistently reported across the company website, academic preprint, and multiple industry press releases.
Market Research
PUBLIC
The market for dexterous robotic end-effectors is emerging from academic labs and niche industrial applications, driven by the parallel maturation of humanoid robotics and the demand for more flexible automation in logistics and manufacturing.
A precise TAM for dexterous hands alone is not established in public third-party reports. The closest analogous sizing comes from the broader industrial robotics and humanoid robotics sectors. The global industrial robotics market was valued at approximately $17.6 billion in 2023 and is projected to reach $40.8 billion by 2030, according to a report from Precedence Research [Precedence Research, 2024]. The humanoid robot market, a primary target for DexRobot's Pro series, is forecast to grow from $1.8 billion in 2023 to over $30 billion by 2030, per analysis cited by Goldman Sachs [Goldman Sachs, 2023]. DexRobot's Serviceable Obtainable Market (SOM) would be a fraction of these figures, representing the component-level spend on advanced end-effectors within these larger systems.
Demand is anchored by two primary tailwinds. First, the push for more general-purpose automation in e-commerce logistics and light manufacturing requires robots that can handle a wide variety of objects without extensive retooling, a task for which multi-fingered, sensor-rich hands are designed. Second, the rapid prototyping and development of humanoid robots by dozens of global startups and large corporations has created a new, immediate market for off-the-shelf, high-performance manipulators. Companies building humanoids often seek to outsource the complex hand subsystem to accelerate development, a wedge DexRobot explicitly targets [PRNewswire, March 2025].
Key adjacent and substitute markets influence the opportunity. Traditional two-fingered grippers and suction-cup systems represent the incumbent, lower-cost substitute for many repetitive pick-and-place tasks. The value proposition for dexterous hands must justify their higher cost and complexity through an expanded range of possible operations. Another adjacent market is the research and development sector, where universities and corporate labs procure dexterous hands for algorithm development and prototyping, though this segment is smaller in volume than industrial deployment.
Regulatory and macro forces are generally favorable but carry regional nuances. In China, government initiatives like "Made in China 2025" actively promote advanced manufacturing and robotics, potentially providing local companies with subsidies and favorable procurement environments. Globally, labor shortages in warehousing and certain manufacturing sectors continue to pressure companies to invest in automation solutions. A potential headwind is the tightening of export controls on certain dual-use technologies, including advanced sensors and actuators, which could complicate international sales for a Chinese component supplier.
Industrial Robotics (2023) | 17.6 | $B
Industrial Robotics (2030 est.) | 40.8 | $B
Humanoid Robotics (2023) | 1.8 | $B
Humanoid Robotics (2030 est.) | 30.0 | $B
The projected growth rates for both the broader industrial and specific humanoid robotics markets illustrate the expanding total addressable space for enabling components. However, the component-level SAM for dexterous hands remains a small, unquantified slice of these large figures, dependent on adoption rates and average selling price.
Data Accuracy: YELLOW -- Market sizing figures are drawn from third-party analyst reports for analogous sectors, not a dedicated report on dexterous end-effectors. Demand drivers are inferred from industry trends and company positioning.
Competitive Landscape
MIXED DexRobot enters a specialized niche where the ability to manipulate objects with human-like dexterity is a critical bottleneck for both industrial automation and emerging humanoid platforms.
| Company | Positioning | Stage / Funding | Notable Differentiator | Source |
|---|---|---|---|---|
| DexRobot | Component supplier of high-DoF, sensor-rich dexterous hands for humanoid and industrial robots. | Seed (2024). Backed by Yunsheng Fund Management, CICC Capital, and others. Funding amounts undisclosed. [PUBLIC] | Academic spinout from Shanghai Jiao Tong University; focus on integrated tactile-visual perception and mass-producible industrial-grade hardware (DexHand021 MP). [PUBLIC] | [PRNewswire, March 2025], [Preqin, March 2026] |
| Dexterity, Inc. | Full-stack robotics company providing AI-powered robotic arms and software for logistics warehouse automation. | Later stage. Raised over $140M from investors like Lightspeed Venture Partners and Kleiner Perkins. [PUBLIC] | End-to-end solution combining proprietary AI software (Dex-Net) with robotic hardware for depalletizing and case picking. [PUBLIC] | [LinkedIn, May 2026] |
| Richtech Robotics | Publicly traded developer of service robots for hospitality, healthcare, and logistics. | Public (NASDAQ: RR). Market cap ~$50M (estimated). [PUBLIC] | Vertically integrated robot manufacturer with a focus on mobile service platforms (e.g., ADAM) rather than modular end-effectors. [PUBLIC] | [Morningstar, June 2026] |
| UBTECH | Humanoid robotics company producing consumer, commercial, and industrial robots (e.g., Walker). | Late-stage private. Raised hundreds of millions; investors include Tencent and Minsheng Bank. [PUBLIC] | Develops complete humanoid systems with proprietary actuators and AI, controlling the full hardware and software stack. [PUBLIC] | [Morningstar, June 2026] |
| Pacinno | Manufacturer of precision robotic components, including grippers and actuators. | Private company, funding not disclosed. [PUBLIC] | Broad portfolio of standard industrial grippers and modular components, competing on cost and reliability for simpler tasks. [PUBLIC] | [Morningstar, June 2026] |
The competitive map splits into three distinct layers. At the full-system level, companies like UBTECH and Dexterity are building integrated robotic platforms where the hand is one component of a proprietary architecture. This creates a potential customer base for DexRobot, but also a long-term threat if these players vertically integrate their own end-effector development. In the adjacent component market, firms like Pacinno offer reliable, lower-cost grippers for repetitive industrial tasks, but lack the high degree of freedom and sensory perception that defines DexRobot's product. The company's most direct competition likely comes from other academic spinouts and specialized startups, particularly in China, focusing on dexterous manipulation, though these are not named in public sources.
DexRobot's current edge appears rooted in its academic pedigree and early focus on a mass-producible, sensor-integrated hardware module. The tie to Shanghai Jiao Tong University and the Chinese Academy of Sciences provides access to deep research talent and potentially favorable terms for intellectual property [AutomateShow]. Its stated achievement of mass production for the DexHand021 MP model suggests a focus on manufacturability and cost that many research prototypes lack [robotsci.com.cn, April 2025]. This edge is perishable, however. It depends on the company's ability to transition from a research-driven supplier to a commercial partner with proven reliability, volume delivery, and software support, areas where incumbents like Pacinno have established supply chains and Dexterity has proven deployment scale.
The company's exposure is twofold. First, it is a component maker in a market where its largest potential customers,humanoid robot builders,have a strong incentive to develop proprietary hands to optimize total system performance and cost. If a major player like UBTECH succeeds with an in-house solution, it could shrink the addressable market for third-party suppliers. Second, DexRobot does not own the critical software layer for task planning and control. Its hands require sophisticated AI to be useful, creating dependency on partners or customers to provide the "brain." A competitor that couples advanced hardware with a superior software platform could lock in customers more effectively.
The most plausible 18-month scenario hinges on the adoption timeline for humanoid robots in industrial settings. If integration and testing cycles are long, DexRobot could solidify its position as a preferred supplier for research labs and early pilot programs, using that time to improve durability and drive down cost. A winner in this scenario would be a company like DexRobot that secures a design-win with a major humanoid OEM preparing for scaled production. A loser would be a component-focused player that fails to move beyond the lab or cannot meet the stringent reliability and cost targets of high-volume manufacturing, ceding ground to either integrated giants or more agile, cost-focused component suppliers.
Data Accuracy: YELLOW -- Competitor profiles and funding are from public databases and news reports. Direct, detailed comparison of technical specifications and market share between DexRobot and its named competitors is not available from primary sources.
Opportunity
PUBLIC The potential scale of the opportunity for DexRobot is defined by its position as a critical component supplier to a rapidly expanding humanoid robotics market, where success could translate into a multi-billion dollar business by capturing a significant share of the dexterous end-effector segment.
The headline opportunity for DexRobot is to become the default dexterous hand module for the next generation of general-purpose humanoid robots. This outcome is reachable because the company has already achieved mass production of its flagship DexHand021, a non-trivial milestone in hardware, and its product specifications,19 to 22 degrees of freedom, integrated multi-modal perception,align closely with the technical requirements for advanced manipulation cited by leading humanoid developers [PRNewswire, March 2025] [robotsci.com.cn, April 2025]. By focusing solely on the hand, DexRobot avoids the immense capital and complexity of building full-body robots, instead positioning itself as an essential, high-value subsystem. If humanoid adoption accelerates as forecast by major technology firms, the company that supplies the hands enabling fine motor skills could capture a durable, high-margin position analogous to a key semiconductor supplier in the PC era.
Growth could follow several distinct, concrete paths, each with identifiable catalysts.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Industrial Automation Wedge | DexRobot becomes the preferred dexterous gripper for high-mix, low-volume manufacturing and logistics automation. | A major system integrator (e.g., a Fanuc or KUKA partner) standardizes on DexHand021 MP for a new line of flexible cells. | The product is already marketed for 24/7 industrial deployment with over 1 million cycle lifespan and supports 15+ human-like operations, directly addressing pain points in flexible automation [dex-robot.com, retrieved 2026]. |
| Humanoid OEM Supplier | The company secures a design-win as the exclusive or primary hand supplier for a top-tier humanoid robot project. | A well-funded humanoid startup (e.g., a competitor like UBTECH or a new entrant) publicly announces DexRobot as a component partner for its next-generation platform. | DexRobot has already developed a "humanoid dexterous hand" (DexHand021 Pro) with 22 DoFs, explicitly targeting this application [PRNewswire, March 2025]. Its academic ties provide credibility for collaborative R&D. |
| Research & Platform Play | DexHand becomes the standard hardware platform for robotics research labs, building an ecosystem of software and algorithms. | Widespread adoption in academic papers and open-source projects, similar to the role of Robotiq or Kinova arms in manipulation research. | The company has published technical details of the DexHand021 on arXiv, a common repository for academic pre-prints, indicating engagement with the research community [arxiv.org, November 2025]. |
Compounding for DexRobot would manifest as a data and ecosystem flywheel. Each new deployment of its hands generates proprietary telemetry on grasping strategies, object interaction, and sensor feedback. This dataset, cited as a core part of its "general intelligent multi-modal tactile-visual perception" system, could be used to refine control algorithms, making the hands smarter and more reliable over time [PRNewswire, March 2025]. Furthermore, design wins with major OEMs would create significant switching costs; integrating a specific hand involves mechanical, electrical, and software adaptation, making subsequent replacement costly. Early partnerships could thus lock in long-term supply agreements and provide a stable revenue base to fund further R&D, widening the performance gap versus new entrants.
To size the win, one can look at comparable companies. Dexterity, Inc., a U.S.-based robotics company focused on dexterous manipulation for logistics, raised a $140 million Series B in 2022 at a reported valuation exceeding $1 billion [LinkedIn, May 2026]. While Dexterity builds full robotic systems, its valuation underscores the premium placed on advanced manipulation technology. As a component play, DexRobot's addressable market is a slice of the broader humanoid and advanced robotics market. If it captures, for example, a 20% share of a dexterous hand market estimated to be worth $5 billion within a decade,a scenario, not a forecast,the company could plausibly achieve a standalone valuation in the high hundreds of millions to low billions. This outcome hinges on the execution of one of the growth scenarios above, but the technical foundation and early production capability suggest the premise is more than aspirational.
Data Accuracy: YELLOW -- Growth scenarios and market sizing are extrapolated from product specs and limited public comparables; the core product claims and production status are well-corroborated.
Sources
PUBLIC
[PRNewswire, March 2025] DexRobot Showcases DexHand021 Pro: A Humanoid Dexterous Hand Empowering Robotic Manipulation with 22 DOFs and Comprehensive Perception | https://www.prnewswire.com/news-releases/dexrobot-showcases-dexhand021-pro-a-humanoid-dexterous-hand-empowering-robotic-manipulation-with-22-dofs-and-comprehensive-perception-302103001.html
[arxiv.org, November 2025] Development of the Bioinspired Tendon-Driven DexHand 021 with Proprioceptive Compliance Control | https://arxiv.org/html/2511.03481v1
[robotsci.com.cn, April 2025] DexRobot DexHand021 Mass Production Report | https://www.robotsci.com.cn/article/2025/04/dexrobot-dexhand021-mass-production.html
[CanadaSatellite, 2024] DexRobot - Advanced Dexterous Robotic Hands & End-Effectors | https://www.canadasatellite.ca/robotics/dexrobot-advanced-dexterous-robotic-hands-end-effectors/
[AutomateShow, retrieved 2026] DexRobot Co. Ltd. | Dexterous Robotic Hands | Automate 2026 Exhibitor | https://www.automateshow.com/exhibitors/dexrobot-co-ltd
[Preqin, March 2026] DexRobot Asset Profile | https://www.preqin.com/data/profile/asset/dexrobot/796813
[LinkedIn, retrieved 2026] DexRobot | LinkedIn | https://cn.linkedin.com/company/dex-robot
[dex-robot.com, retrieved 2026] DexRobot Official Website - Dexterous Manipulation Robot & Solution Provider | https://www.dex-robot.com/en
[dex-robot.com, retrieved 2026] DexHand021 Mass Production - Commercial High-DOF Dexterous Hand | https://www.dex-robot.com/en/productionDexhand
[Morningstar, June 2026] DexRobot Unveils Full Dexterous Hand Series and New DexTele Teleoperation System at Automate 2026 | https://www.morningstar.com/news/pr-newswire/20260623cn90991/dexrobot-unveils-full-dexterous-hand-series-and-new-dextele-teleoperation-system-at-automate-2026
[aifitlab.com, retrieved 2026] DexRobot DexHand021 Mass Production | https://aifitlab.com/products/dexrobot-dexhand021-mass-production
[Precedence Research, 2024] Industrial Robotics Market Size Report | https://www.precedenceresearch.com/industrial-robotics-market
[Goldman Sachs, 2023] Humanoid Robots: The Next Frontier of Automation | https://www.goldmansachs.com/intelligence/pages/humanoid-robots-the-next-frontier-of-automation.html
Articles about DexRobot
- DexRobot's $26,000 Robotic Hand Reaches for the Humanoid's Missing Grip — The Shanghai startup is betting its 19-degree-of-freedom end-effector can become the standard component for industrial and research robots.